Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Loveman

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
The Cochrane Database of Systematic Reviews|December 17, 2020
Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age-related macular degenerationJian Lee Yeong, Emma Loveman, Jill L Colquitt, et al.
Pharmacoeconomics|February 20, 2019
Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology AppraisalHema Mistry, Chidozie Nduka, Martin Connock, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|March 16, 2019
Autograft or allograft for reconstruction of anterior cruciate ligament: a health economics perspectiveHema Mistry, Andrew Metcalfe, Jill Colquitt, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|March 24, 2019
Allografts in reconstruction of the posterior cruciate ligament: a health economics perspectiveNorman Waugh, Hema Mistry, Andrew Metcalfe, et al.
Health Technology Assessment (Winchester, England)|May 31, 2018
Treatments for dry age-related macular degeneration and Stargardt disease: a systematic reviewNorman Waugh, Emma Loveman, Jill Colquitt, et al.
Pharmacoeconomics|February 13, 2020
Ocrelizumab for Treating Patients with Primary Progressive Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology AppraisalPeter Auguste, Jill Colquitt, Martin Connock, et al.
Pharmacoeconomics|December 10, 2017
Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology AppraisalHema Mistry, Chidozie Nduka, Martin Connock, et al.
Expert Review of Cardiovascular Therapy|February 6, 2008
Cost-effectiveness of left ventricular-assist devices in end-stage heart failureJulia Hutchinson, David A Scott, Andrew J Clegg, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|April 15, 2019
Meniscal allograft transplantation after meniscectomy: clinical effectiveness and cost-effectivenessNorman Waugh, Hema Mistry, Andrew Metcalfe, et al.
BMC Pulmonary Medicine|May 1, 2015
Comparing new treatments for idiopathic pulmonary fibrosis--a network meta-analysisEmma Loveman, Vicky R Copley, David A Scott, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
The Cochrane Database of Systematic Reviews|December 17, 2020
Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age-related macular degenerationJian Lee Yeong, Emma Loveman, Jill L Colquitt, et al.
Pharmacoeconomics|February 20, 2019
Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology AppraisalHema Mistry, Chidozie Nduka, Martin Connock, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|March 16, 2019
Autograft or allograft for reconstruction of anterior cruciate ligament: a health economics perspectiveHema Mistry, Andrew Metcalfe, Jill Colquitt, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|March 24, 2019
Allografts in reconstruction of the posterior cruciate ligament: a health economics perspectiveNorman Waugh, Hema Mistry, Andrew Metcalfe, et al.
Health Technology Assessment (Winchester, England)|May 31, 2018
Treatments for dry age-related macular degeneration and Stargardt disease: a systematic reviewNorman Waugh, Emma Loveman, Jill Colquitt, et al.
Pharmacoeconomics|February 13, 2020
Ocrelizumab for Treating Patients with Primary Progressive Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology AppraisalPeter Auguste, Jill Colquitt, Martin Connock, et al.
Pharmacoeconomics|December 10, 2017
Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology AppraisalHema Mistry, Chidozie Nduka, Martin Connock, et al.
Expert Review of Cardiovascular Therapy|February 6, 2008
Cost-effectiveness of left ventricular-assist devices in end-stage heart failureJulia Hutchinson, David A Scott, Andrew J Clegg, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|April 15, 2019
Meniscal allograft transplantation after meniscectomy: clinical effectiveness and cost-effectivenessNorman Waugh, Hema Mistry, Andrew Metcalfe, et al.
BMC Pulmonary Medicine|May 1, 2015
Comparing new treatments for idiopathic pulmonary fibrosis--a network meta-analysisEmma Loveman, Vicky R Copley, David A Scott, et al.
Pageof 5